Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Epigenetic driver of glioblastoma provides new therapeutic target

  • Bacterial biofilms may play a role in lupus, research finds

  • New smartphone app warns drinkers if they go over recommended daily/weekly units

  • Gym steroid use has impact on memory

  • Enriched blood cells preserve cognition in mice with features of Alzheimer's disease

  • Brain abnormalities in people with schizophrenia identified

  • Mascots: Can a humanlike figure actually harm a company?

  • Reusable shopping bags encourage shoppers to buy produce -- and junk food?

  • Yes, it pays to win back lost customers

  • Can a humanlike figure actually harm a company?

  •